(Jackson Laboratory) With a new two-year, $1 million grant from the National Cancer Institute, Jackson Laboratory Professor Gary Churchill is launching a radical new approach to testing three chemotherapeutic drugs for potential toxic effects, using an outbred mouse population that approximates the genetic diversity observed in human populations.